Organon Pharma Indonesia PT (ISX:SCPI) Margin of Safety % (DCF FCF Based) : N/A (As of May. 15, 2024)

View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Organon Pharma Indonesia PT's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

Competitive Comparison of Organon Pharma Indonesia PT's Margin of Safety % (DCF FCF Based)

For the Drug Manufacturers - Specialty & Generic subindustry, Organon Pharma Indonesia PT's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Organon Pharma Indonesia PT's Margin of Safety % (DCF FCF Based) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organon Pharma Indonesia PT's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Organon Pharma Indonesia PT's Margin of Safety % (DCF FCF Based) falls into.

Organon Pharma Indonesia PT Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Margin of Safety % (DCF FCF Based)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920

Website

https://www.organon.com/indonesia

Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines